Straits Times Index
3,321.99 +7.85 (+0.24%) Nikkei
39,087.66 +283.01 (+0.73%) Hang Seng
18,111.36 +83.65 (+0.46%) FTSE 100
8,281.55 +43.83 (+0.53%) Bitcoin USD
61,312.80 -1,259.55 (-2.01%) CMC Crypto 200
1,274.43 -35.29 (-2.69%)
Indivior PLC (2IVB.SG)
| Previous close | 15.50 |
| Open | 15.70 |
| Bid | 15.20 x N/A |
| Ask | 15.70 x N/A |
| Day's range | 15.10 - 15.70 |
| 52-week range | 13.02 - 21.90 |
| Volume | |
| Avg. volume | 147 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireIndivior Announces the Publication of New Data on the Comparative Effectiveness of Intranasal (IN) Nalmefene (OPVEE 2.7mg) and IN Naloxone (4 mg) in a Translational Model Assessing the Impact of a Synthetic Opioid Overdose on Respiratory Depression and Cardiac Arrest
Indivior PLC (LSE/Nasdaq: INDV) today announced the publication of a modeling study in Frontiers in Psychiatry that predicts OPVEE (nalmefene) nasal spray (2.7 mg nalmefene, equivalent to 3 mg of nalmefene hydrochloride) resulted in larger reductions in the incidence of simulated cardiac arrest following overdose from high doses of potent synthetic opioids, compared to a 4 mg dose of IN naloxone.
- PR Newswire
Indivior Announces Dosing of First Subject with INDV-2000 in a Phase 2 Study Assessing the Safety and Efficacy of INDV-2000 in Individuals with Opioid Use Disorder
Indivior PLC (LSE/Nasdaq: INDV) today announced the dosing of the first subject with INDV-2000 in a Phase 2 double-blind, placebo controlled, randomized, dose-ranging study to assess the safety and efficacy of INDV-2000 over 3 months in treatment-seeking individuals with Opioid Use Disorder (OUD) (NCT06384157). The purpose of this proof-of-concept study is to measure safety and efficacy and to determine the dose-response relationship for INDV-2000 in participants with moderate to severe OUD who
Simply Wall St.With 59% ownership, Indivior PLC (LON:INDV) boasts of strong institutional backing
Key Insights Institutions' substantial holdings in Indivior implies that they have significant influence over the...
